NCT04793789 is a clinical trial of monofocal toric lens in Cataract Senile, sponsored by Carl Zeiss Meditec AG.

Who is sponsoring NCT04793789?

NCT04793789 is sponsored by Carl Zeiss Meditec AG.

What drugs are being tested in NCT04793789?

Interventions in NCT04793789: monofocal toric lens.

What condition does NCT04793789 study?

NCT04793789 studies Cataract Senile.

Is NCT04793789 still recruiting?

NCT04793789 is currently completed. Last updated 5 May 2022.

Last reviewed 2022-05-05 · How we verify

NCT04793789

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of an Hydrophilic Acrylic Intraocular Lens

Completed Last updated 5 May 2022

What this trial tests

trial testing monofocal toric lens in Cataract Senile in 249 participants. Completed in 24 January 2022.

Timeline

27 April 2021

Primary endpoint
24 January 2022

24 January 2022

Quick facts

Lead sponsor	Carl Zeiss Meditec AG
Status	Completed
Study type	OBSERVATIONAL
Enrollment	249
Start date	27 April 2021
Primary completion	24 January 2022
Estimated completion	24 January 2022
Sites	1 location across France

Drugs / interventions tested

monofocal toric lens

Conditions studied

Cataract Senile — all drugs for Cataract Senile →

Sponsor

Carl Zeiss Meditec AG — full company profile →

Who can join

18 and older, any sex, with Cataract Senile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the clinical safety and effectiveness of hydrophilic acrylic intraocular lens

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cataract Senile

Currently open trials in the same condition.

NCT04570579 — Impact of a Novel Extended Depth of Focus Intraocular Lens on Visual and Lifestyle Enhancement · active not recruiting

Other Carl Zeiss Meditec AG trials

Trials by the same sponsor.

NCT07471295 — Toric Performance And Constant Evaluation · Phase 4 · not yet recruiting
NCT07297719 — Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation · completed
NCT06192901 — Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery · completed
NCT06247683 — Study to Confirm Safety and Performance of a New Multifocal IOL · NA · completed
NCT05646004 — 621 Real World Study · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04793789 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carl Zeiss Meditec AG
Last refreshed: 5 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793789.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing